Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
Nutricion Hospitalaria|February 7, 2015
[Prebiotics: concept, properties and beneficial effects]N Corzo, J L Alonso, F Azpiroz, et al.
BMC Palliative Care|May 29, 2026
Midazolam prescription as a trigger for potential deceased donor identification outside the ICU: a prospective feasibility studyJ A Encarnación, B Domínguez-Gil, C Pellicer, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|April 7, 2021
Routine anti-reflux surgery combined with gastrostomy in children: is it really necessary? Our single-center experienceP Guillén Redondo, R Espinosa Góngora, A L Luis Huertas, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|July 7, 2023
Hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation: experience in a pediatric oncological institutionS de la Puente, M L Espinoza, I Carrillo, et al.
British Journal of Pharmacology|April 17, 2008
AM3, a natural glycoconjugate, induces the functional maturation of human dendritic cellsS Martín-Vilchez, F Molina-Jiménez, J L Alonso-Lebrero, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|March 20, 2018
Device-Compatible Chiroptical Surfaces through Self-Assembly of Enantiopure AllenesA Ozcelik, R Pereira-Cameselle, A von Weber, et al.
Astronomy and Astrophysics|November 17, 2017
Discovery of methyl silane and confirmation of silyl cyanide in IRC +10216J Cernicharo, M Agúndez, L Velilla Prieto, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|January 11, 2023
Pediatric perianal Crohn's disease behavior in the era of biologic therapyS De La Puente, R Espinosa Góngora, H Souto Romero, et al.
Cancers|March 14, 2026
Clinical Complete Response and Organ Preservation Strategies in Rectal Cancer: A Real-World Single-Center Experience Clinical Complete Response and Organ Preservation in Rectal CancerJ A Encarnación, N Ibáñez, I De la Fuente, et al.
BMC Cancer|December 3, 2022
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) studyL de la Cruz-Merino, M Gion, J Cruz, et al.
Pageof 26